CClinicalTrials.gg
CompletedNCT04405336Updated May 25, 2021

Tab Block and Patient Controlled Analgesia in CS

An interventional study of tab block and PCA in Analgesia, sponsored by Aljazeera Hospital. Completed at 1 site in Egypt. Open to female participants aged 18 Years to 42 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-05-25.

Sponsored by Aljazeera Hospital · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
140
Allocation
Randomized
Ages
18 Years to 42 Years
Sex
Female
01

Study summary

cesarean section rate become increasing nowadays

Read the detailed description

indication of cesarean section are different from case to case and the use of pain controlling agents is very important to relieve post operative pain

02

Conditions studied

  • Analgesia

Browse trials for

03

In context

Agnosia

1,189 studies on the registry are indexed under Agnosia; 507 are open to participants now.

This study's enrollment of 140 is above the median of 77 across 1,023 interventional studies indexed under Agnosia.

Browse Agnosia studies →

Lead sponsor

Aljazeera Hospital is the lead sponsor of 63 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 42 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • women coming for an elective CS

Exclusion criteria

Exclusion Criteria:

  • women who has a n emergency CS or complicated normal deivery needs urgent CS
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
140 participants (actual)

Study arms

  • Active comparator
    giving tab block

    giving patients tab block

    Drug: tab block · Drug: women who will not receive tab block or PCA

  • Active comparator
    giving PCA

    Giving PCA to patients

    Drug: PCA · Drug: women who will not receive tab block or PCA

  • No intervention
    Patients who will not receive PCA or tab block

    No tab block or PCA

Interventions

  • Drugtab block

    injection of tab block to women who are doing cs

  • DrugPCA

    giving women PCA

  • Drugwomen who will not receive tab block or PCA

    no tab block or PCA will be given

06

What researchers measure

Primary outcomes

  1. The number of women who will feel less pain post CS

    the degree of pain that will be felt post CS

    Time frame: 2 days

07

Study locations

1 site
  • Aljazeera( Al Gazeera) hospital
    Giza, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 25, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04405336
Lead sponsor
Aljazeera Hospital
Responsible party
Sponsor
First posted
May 28, 2020
Start date
May 28, 2020
Primary completion
Mar 15, 2021
Completion
Apr 1, 2021
Last update
May 25, 2021

Study contacts

Mahmoud Alalfy, PhD
study chair · Algezeera hospitaland National Research Centre ,Egypt

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion